Dr. Tim Ioannides, MD

Dr. Ioannides practices at Treasure Coast Dermatology in Port Saint Lucie, Florida.

Dr. Ioannides' NPI, 1952369779, was assigned on May 2, 2006. Dr. Ioannides graduated from University of Miami, Miller School of Medicine in 1993. Dr. Ioannides holds Florida license ME0073425.

Dr. Ioannides' primary practice is Treasure Coast Dermatology, at 140 Sw Chamber Ct, Port Saint Lucie, FL 34986-3414. The practice phone is (772) 878-3376.

Dr. Ioannides' primary practice is Treasure Coast Dermatology in Port Saint Lucie, Florida. Dr. Ioannides is also affiliated with Cleveland Clinic Martin North Hospital. Dmand AI also links Dr. Ioannides to 1 more hospital, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ioannides practices, 3 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Ioannides' primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Ioannides is board certified in dermatology by the American Board of Dermatology. Dr. Ioannides is licensed in Florida.

Dmand AI lists acne, acute skin infection, benign or precancerous skin growths, cancerous skin growth removal, cold sores or genital herpes, contact dermatitis, facial skin infection and hives among the conditions Dr. Ioannides treats.

CMS data shows 34,556 Medicare services from Dr. Ioannides across 53 procedure codes in 2024, for 1,696 Medicare patients. Medicare paid $2,334,232 for them. Every service was in an office.

CMS counts 1,696 Medicare patients who saw Dr. Ioannides in 2024. The largest group is 75 to 84, with 836 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 5% are also on Medicaid. Their average risk score is 1.30, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Ioannides' median patient age at 80, with 44% women.

In 2024, Dr. Ioannides wrote 4,824 Medicare Part D claims for 1,296 patients. 93% of them were for generic drugs. CMS names the drug for 4,680 of them, across 29 drugs with 11 or more claims each, at $196,019 in total drug cost. In 2023, CMS named 5,139 claims across 32 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Ioannides for performance year 2024, reported individually. Dr. Ioannides accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 7,292 procedures of removal of skin lesions by Dr. Ioannides, more than 99% of the clinicians it reports for that procedure.

Dmand AI links 14 papers to Dr. Ioannides, published from 2018 to 2024. 2018 was the busiest year, with 2. The most frequent topics are Papillomavirus Infections, Papillomavirus Vaccines and Carcinoma, Squamous Cell. Dr. Ioannides has published most often in JAAD Case Rep. Dr. Ioannides' most frequent co-authors are Anna Jeannine Nichols, MD, PhD, Robert S. Kirsner, MD and Evangelos V. Badiavas, MD.

CMS Open Payments shows 1 general payment to Dr. Ioannides from 1 drug or device company in 2020. Education make up the largest share, 100% of the total. Genentech, Inc. paid the most, $13.

Dmand AI lists 2 awards for Dr. Ioannides.

Dr. Ioannides graduated from University of Miami, Miller School of Medicine in 1993. Dr. Ioannides is a member of AAD and ASDS.

Dr. Ioannides is in network with 3 carriers, including Excellus BlueCross BlueShield, Humana and CMS Medicare. Medicare plans come from the most carriers, 3. Check the plan with the practice before a visit.